Table 1.
Characteristics of recruited subjects in this study.
Variable | Healthy subjects (n = 42) | Patients with ovarian endometriomas (n = 45) | p value |
---|---|---|---|
Age (in years) | |||
Mean ± S.D | 33.6 ± 7.6 | 33.0 ± 6.6 | 0.99 |
Median (range) | 32(23–49) | 32(22–48) | |
Menstrual phase | |||
Proliferative | ND | 22 (48.9%) | NA |
Secretory | 23 (51.1%) | ||
Parity | |||
0 | 20 (47.6%) | 23 (51.1%) | 0.71 |
1 | 18 (42.9%) | 20 (44.4%) | |
≥ 2 | 4 (9.5%) | 2 (4.4%) | |
rASRM score | |||
Mean ± S.D | NA | 38.8 ± 16.97 | NA |
Median (range) | 48(4–76) | ||
rASRM stage | |||
I | NA | 1 (2.2%) | NA |
II | 0 (0.0%) | ||
III | 24 (53.3%) | ||
IV | 20 (44.4%) | ||
Severity of dysmenorrhea | |||
None | 35(83.3%) | 19 (43.2%) | 0.0003 |
Mild | 4 (9.5%) | 19 (43.2%) | |
Moderate | 3 (7.1%) | 6 (13.3%) | |
Severe | 0 (0.0%) | 1 (2.2%) | |
Co-occurrence with uterine fibroids | |||
No | 36 (85.7%) | 34 (75.6%) | 0.29 |
Yes | 6 (14.3%) | 11 (24.4%) | |
Co-occurrence with adenomyosis | |||
No | 42 (100.0%) | 39 (86.7%) | 0.056 |
Yes | 0 (0.0%) | 6 (13.3%) | |
Co-occurrence with deep endometriosis | |||
No | 42 (100.0%) | 43 (95.6%) | 0.49 |
Yes | 0 (0.0%) | 2 (4.4%) |
rASRM revised American Society for Reproductive Medicine classification system for endometriosis, ND not determined, NA not applicable.